Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tahany Awad

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Cochrane Database of Systematic Reviews|March 4, 2014
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis CGoran Hauser, Tahany Awad, Jesper Brok, et al.
Therapeutic Advances in Gastroenterology|February 6, 2026
Patient-reported benefits of colonoscopicallyadministered microbiota restoration therapy: a qualitative study of adult patients with recurrent <i>Clostridioides difficile</i> infectionMegan McCool-Myers, Cindy Umanzor-Figueroa, Tara Symonds, et al.
Hepato-Gastroenterology|March 18, 2014
Clinical, biochemical and pathological profiles of 5464 Egyptian chronic hepatitis C-infected patientsMahasen Mabrouk, Maissa El-Raziky, Naglaa Zayed, et al.
Plos One|August 1, 2012
Evolution of heterogeneity (I2) estimates and their 95% confidence intervals in large meta-analysesKristian Thorlund, Georgina Imberger, Bradley C Johnston, et al.
Plos One|July 27, 2019
Incidence, prevalence and risk factors for hepatitis C in Danish prisonsJacob Søholm, Dorte Kinggaard Holm, Belinda Mössner, et al.
Therapeutic Advances in Gastroenterology|November 13, 2025
Prevention of recurrent <i>Clostridioides difficile</i> infection by fecal microbiota, live-jslm (REBYOTA<sup>®</sup>) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trialSahil Khanna, David Yoho, Daniel Van Handel, et al.
Therapeutic Advances in Gastroenterology|May 5, 2025
Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA<sup>®</sup>) administered by colonoscopy for prevention of recurrent <i>Clostridioides difficile</i> infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trialSahil Khanna, David Yoho, Daniel Van Handel, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 26, 2012
World Health Organization Guidelines: Use of cryotherapy for cervical intraepithelial neoplasiaNancy Santesso, Holger Schünemann, Paul Blumenthal, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Cochrane Database of Systematic Reviews|March 4, 2014
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis CGoran Hauser, Tahany Awad, Jesper Brok, et al.
Therapeutic Advances in Gastroenterology|February 6, 2026
Patient-reported benefits of colonoscopicallyadministered microbiota restoration therapy: a qualitative study of adult patients with recurrent <i>Clostridioides difficile</i> infectionMegan McCool-Myers, Cindy Umanzor-Figueroa, Tara Symonds, et al.
Hepato-Gastroenterology|March 18, 2014
Clinical, biochemical and pathological profiles of 5464 Egyptian chronic hepatitis C-infected patientsMahasen Mabrouk, Maissa El-Raziky, Naglaa Zayed, et al.
Plos One|August 1, 2012
Evolution of heterogeneity (I2) estimates and their 95% confidence intervals in large meta-analysesKristian Thorlund, Georgina Imberger, Bradley C Johnston, et al.
Plos One|July 27, 2019
Incidence, prevalence and risk factors for hepatitis C in Danish prisonsJacob Søholm, Dorte Kinggaard Holm, Belinda Mössner, et al.
Therapeutic Advances in Gastroenterology|November 13, 2025
Prevention of recurrent <i>Clostridioides difficile</i> infection by fecal microbiota, live-jslm (REBYOTA<sup>®</sup>) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trialSahil Khanna, David Yoho, Daniel Van Handel, et al.
Therapeutic Advances in Gastroenterology|May 5, 2025
Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA<sup>®</sup>) administered by colonoscopy for prevention of recurrent <i>Clostridioides difficile</i> infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trialSahil Khanna, David Yoho, Daniel Van Handel, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 26, 2012
World Health Organization Guidelines: Use of cryotherapy for cervical intraepithelial neoplasiaNancy Santesso, Holger Schünemann, Paul Blumenthal, et al.
Pageof 2